328 related articles for article (PubMed ID: 17207659)
1. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
[TBL] [Abstract][Full Text] [Related]
2. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
3. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
4. A novel function of EpCAM in oral squamous cell carcinoma cells under anchorage-independent conditions.
Inoue H; Ohnishi Y; Nakajima M; Kakudo K; Nozaki M
Int J Oncol; 2011 Dec; 39(6):1401-5. PubMed ID: 21785818
[TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Yoshida H; Yoshitomi I; Kawasaki G; Mizuno A; Nemoto TK
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):61-7. PubMed ID: 19913389
[TBL] [Abstract][Full Text] [Related]
6. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
Li S; Jiao J; Lu Z; Zhang M
Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298
[TBL] [Abstract][Full Text] [Related]
7. Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer.
Andratschke M; Hagedorn H; Luebbers CW; Schmitt B; Lang S; Zeidler R; Wollenberg B
Anticancer Res; 2006; 26(1A):153-8. PubMed ID: 16475692
[TBL] [Abstract][Full Text] [Related]
8. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Martowicz A; Spizzo G; Gastl G; Untergasser G
BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
[TBL] [Abstract][Full Text] [Related]
9. FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.
Zheng X; Jia B; Lin X; Han J; Qiu X; Chu H; Sun X; Hu W; Pan J; Chen J; Zhao J
Int J Mol Med; 2016 Nov; 38(5):1443-1449. PubMed ID: 27666346
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer.
Abd El-Maqsoud NM; Abd El-Rehim DM
Clin Breast Cancer; 2014 Feb; 14(1):e1-9. PubMed ID: 24201161
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Kawasaki G; Rokutanda S; Yonezawa H; Kawakita A; Nemoto TK
Cancer Lett; 2011 Apr; 303(2):84-91. PubMed ID: 21339045
[TBL] [Abstract][Full Text] [Related]
13. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder.
Brunner A; Prelog M; Verdorfer I; Tzankov A; Mikuz G; Ensinger C
J Clin Pathol; 2008 Mar; 61(3):307-10. PubMed ID: 17586680
[TBL] [Abstract][Full Text] [Related]
14. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
[TBL] [Abstract][Full Text] [Related]
15. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases.
Cimino A; Halushka M; Illei P; Wu X; Sukumar S; Argani P
Breast Cancer Res Treat; 2010 Oct; 123(3):701-8. PubMed ID: 20012351
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/cancer cell adhesion.
Usami Y; Ishida K; Sato S; Kishino M; Kiryu M; Ogawa Y; Okura M; Fukuda Y; Toyosawa S
Int J Cancer; 2013 Aug; 133(3):568-78. PubMed ID: 23364881
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of EpCAM expression in human esophageal cancer.
Kimura H; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Kuwano H
Int J Oncol; 2007 Jan; 30(1):171-9. PubMed ID: 17143526
[TBL] [Abstract][Full Text] [Related]
19. The involvement of promoter methylation and DNA methyltransferase-1 in the regulation of EpCAM expression in oral squamous cell carcinoma.
Shiah SG; Chang LC; Tai KY; Lee GH; Wu CW; Shieh YS
Oral Oncol; 2009 Jan; 45(1):e1-8. PubMed ID: 18485790
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.
Sen S; Carnelio S
Histopathology; 2016 May; 68(6):897-904. PubMed ID: 26401964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
